A NEW drug stops multiple sclerosis in its tracks!
The experimental drug beat a standard medication in reducing MS relapses — preventing them in nine out of ten patients with the crippling autoimmune disease, according to researchers.
You can read up to 3 premium stories before you subscribe to Magzter GOLD
Log in, if you are already a subscriber
Get unlimited access to thousands of curated premium stories, newspapers and 5,000+ magazines
READ THE ENTIRE ISSUE
August 31, 2020